Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective R-cadherin antagonist and methods

Selective R-cadherin antagonist and methods

US Patent 7419953 · Granted Sep 2, 2008

Estimated economic value: $5,258,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cone cell degeneration with transfected lineage negative hematopoie2014
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of a2014
Selective R-cadherin antagonists and methods2012
Selective R-cadherin antagonists and methods2012
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of a2011
Isolated myeloid-like bone marrow cell populations and methods of treatment ther2011
Hematopoietic stem cells and methods of treatment of neovascular eye diseases th2010
Methods and compositions for the treatment of diseases of the eye2010
Integrin inhibitors for the treatment of eye diseases2010
Compositions and methods for treatment of neovascular diseases2009
Compositions and methods for treatment of neovascular diseases2009
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of a2009